Global Coronavirus Diagnostics Market 2021-2026: Europe and Asia-Pacific are Expected to Dominate the Market

News provided by

Jul 09, 2021, 10:30 ET

DUBLIN, July 9, 2021 /PRNewswire/ -- The "Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single), By Full Test Time (1 Hour - 12 Hours, Less Than 60 Minutes, 13 Hours - 24 Hours, More Than 1 Day), By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

The Global Coronavirus Diagnostics Market was valued at USD73,538.02 million in 2020 and is expected to reach USD15579.56 million by 2026.

The Global Coronavirus Diagnostics Market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end-user, company and region. Based on type of test, the market can be bifurcated into molecular and serological tests.

The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

Europe and Asia-Pacific are expected to dominate the market during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions.

Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc., Hologic, Inc., Quidel Corporation, and others

Key Target Audience:

Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to coronavirus diagnostics
Market research and consulting firms

Years considered for this report:

Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022-2026

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Coronavirus Diagnostics Market

5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Pricing Analysis
5.5. Unmet Needs/Challenges

6. Global Coronavirus Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type of Test (Molecular v/s Serology)
6.2.2. By User (Multiple v/s Single)
6.2.3. By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)
6.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map

7. Europe Coronavirus Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type of Test
7.2.2. By User
7.2.3. By Full Test Time
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. United Kingdom Coronavirus Diagnostics Market Outlook
7.3.2. Russia Coronavirus Diagnostics Market Outlook
7.3.3. France Coronavirus Diagnostics Market Outlook
7.3.4. Italy Coronavirus Diagnostics Market Outlook
7.3.5. Germany Coronavirus Diagnostics Market Outlook
7.3.6. Spain Coronavirus Diagnostics Market Outlook

8. Asia-Pacific Coronavirus Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type of Test
8.2.2. By User
8.2.3. By End User
8.2.4. By Full Test Time
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. India Coronavirus Diagnostics Market Outlook
8.3.2. China Coronavirus Diagnostics Market Outlook
8.3.3. Australia Coronavirus Diagnostics Market Outlook
8.3.4. Japan Coronavirus Diagnostics Market Outlook
8.3.5. Singapore Coronavirus Diagnostics Market Outlook
8.3.6. South Korea Coronavirus Diagnostics Market Outlook
8.3.7. Thailand Coronavirus Diagnostics Market Outlook

9. North America Coronavirus Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type of Test
9.2.2. By User
9.2.3. By Full Test Time
9.2.4. By End User
9.2.5. By Country
9.3. North America: Country Analysis
9.3.1. United States Coronavirus Diagnostics Market Outlook
9.3.2. Canada Coronavirus Diagnostics Market Outlook
9.3.3. Mexico Coronavirus Diagnostics Market Outlook

10. Middle East & Africa Coronavirus Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type of Test
10.2.2. By User
10.2.3. By Full Test Time
10.2.4. By End User
10.2.5. By Country
10.3. Middle East & Africa: Country Analysis
10.3.1. UAE Coronavirus Diagnostics Market Outlook
10.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook
10.3.3. Iran Coronavirus Diagnostics Market Outlook
10.3.4. South Africa Coronavirus Diagnostics Market Outlook
10.3.5. Kuwait Coronavirus Diagnostics Market Outlook

11. South America Coronavirus Diagnostics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Type of Test
11.2.2. By User
11.2.3. By Full Test Time
11.2.4. By End User
11.2.5. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Coronavirus Diagnostics Market Outlook
11.3.2. Colombia Coronavirus Diagnostics Market Outlook
11.3.3. Argentina Coronavirus Diagnostics Market Outlook

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/505zi8

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets